viewJPMorgan Chase & Co

JPMorgan and the German government squash rumors of a potential investment in Deutsche Bank

A weekly German publication alleged that JPMorgan and a Chinese bank were going to invest in Deutsche Bank

Deutsche Bank
The US bank and the German government have both denied the claims

Rumors have been swirling around JPMorgan Chase & Co (NYSE:JPM) and Deutsche Bank (NYSE:DB), suggesting that the US bank was interested in a stake in the German giant.

German magazine WirtschaftsWoche said that JPMorgan and the Industrial and Commercial Bank of China were interested in investing in Deutsche Bank, according to a Reuters report.

The publication alleged that Chancellor Angela Merkel met with Alex Weber, the chairman of Swiss bank UBS and the former head of Bundesbank.

JPMorgan and the German government have squashed the gossip, stating that there is no truth to the claims.

"We are denying the story, it is not true,” stated a JPMorgan spokeswoman.

"We were astonished to learn about the report about a supposed conversation between the chancellor and Mr. Weber. It is purely speculative and cannot be confirmed,” said government spokesman Steffen Seibert in a news conference.

Seibert added that the German government has full trust in the flagship bank.

Shares of JPMorgan were up slightly to US$104.45 while shares of Deutsche Bank were up nearly 4% to US$11.52 in Friday pre-market trading.


Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

Quick facts: JPMorgan Chase & Co

Price: 132.34 USD

Market: NYSE
Market Cap: $415.08 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Akerna 'widening its competitive moat' with rollup strategy...

Akerna Corp (NASDAQ:KERN) CEO Jessica Billingsley tells Proactive the Denver, Colorado-based cannabis-focused regulatory compliance technology company is looking to 'widen its competitive moat' with recent investment into anti-counterfeit technology platform solo sciences inc. Billingsley...

21 minutes ago

2 min read